Thermo Fisher Scientific TMO
Valuation
Multiples measured against the stock's own five-year history
Near the top of its 5-year range · 88th percentile, 5-year average 31.7x
#2304 of 2972 stocks by PE (1 = cheapest)
Around its usual level · 54th percentile, 5-year average 4.5x
#4281 of 5311 stocks by PB (1 = cheapest)
Near the top of its 5-year range · 87th percentile, 5-year average 4.8x
#3995 of 5150 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 4.71 | – | 4.54 | 54% (pricier than usual) | #4281 of 5311 (1 = cheapest) |
| PE | 36.76 | 33.52 | 31.68 | 88% (pricier than usual) | #2304 of 2972 (1 = cheapest) |
| PS | 5.44 | 5.18 | 4.85 | 87% (pricier than usual) | #3995 of 5150 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on TMO.
Sign in to join the discussion.